Background/Objectives: Folate has been recognized to ensure reproductive health and there is a growing body of epidemiological evidence suggesting that the methylenetetrahydrofolate reductase (MTHFR) 677T allele and reduced dietary folate may increase the risk of cervical cancer. The main focus of our survey was to investigate the distribution of the MTHFR C677T polymorphism in relation to women's year of birth and to assess their folate intake and folic acid supplementation. Subjects/Methods: During a 6-months period, 307 healthy women of childbearing age in Catania, Italy, were enrolled in the cross-sectional study. Folate intake was estimated by a semiquantitative food frequency questionnaire and DNA extracted from blood samples for MTHFR C677T genotyping. Results: A TT genotype frequency of 20.5% with an increase in the prevalence of the TT genotype in the cohort of women born since 1959 was shown. The prevalence of inadequate folate intake was 51.5%, significantly higher in non-pregnant women (83.4%) than in pregnant ones (12.3%) with a decrease during the three trimesters of pregnancy (from 25.7 to 5.0%; P ¼ 0.013). The use of folic acid supplements improved during the three trimester of pregnancy (from 71.4 to 95.0%; P ¼ 0.001).
Introduction
Adequate maternal nutrition during the periconceptional period as well as in pregnancy are key focus of attention in public health because of the increased needs and greater vulnerability of pregnant women to the effects of micronutrient deficiency or imbalance (Ortiz-Andrellucchi et al., 2009) . The effect of folate status on pregnancy outcomes has long been recognized. Folate is now viewed not only to prevent megaloblastic anemia in pregnancy but also to ensure reproductive health, disease prevention and health maintenance (Tamura and Picciano, 2006) . Although there is a growing body of epidemiological evidence suggesting that folate deficiency contributes to cancer risk at several sites, findings on cervical cancer risk have been inconsistent (Flatley et al., 2009) .
Epidemiological and molecular studies have shown a causal relation between infection with high-risk human papillomaviruses (HPVs) and cervical cancer. Nutritional status and food consumption may be important HPV cofactors that increase risk of persistence and progression to cervical intraepithelial neoplasia (CIN; Garcia-Closas et al., 2005) . Previous research has shown that high folate status significantly influences the natural history of infections with high-risk HPV (Piyathilake et al., 2004) and lower likelihood of developing high-risk HPV-associated CIN grades higher than 2 (CIN 2 þ ; Piyathilake et al., 2007 Piyathilake et al., , 2009 ). The apparent role of folate in cervical carcinogenesis has lead to the interest in folate metabolism enzymes that may be the cofactors linking folate deficiency and cervical carcinogenesis. Methylenetetrahydrofolate reductase (MTHFR) regulates the metabolism of folate and methionine, which are important factors in DNA methylation and synthesis. The MTHFR C677T polymorphism can lead to abnormal DNA methylation and DNA synthesis, possibly leading to an increased risk of cancer. However, the effect of MTHFR polymorphisms on cancer and precancer susceptibility remains controversial.
We have previously reported a decreased risk for CIN of individuals homozygous for the MTHFR T allele (Agodi et al., 2010) . However, some studies have supported the existence of gene-folate status interactions in the etiology of cervical cancer, and specifically it has been reported that MTHFR T allele and reduced dietary folate may increase the risk for cervical squamous intraephitelial lesions (Goodman et al., 2001) , while, on the contrary, a study conducted after folic acid fortification reported that MTHFR polymorphism is associated with reduced risk of CIN 2 or 3 (Henao et al., 2005) .
The present cross-sectional study was conducted on women of childbearing age in Catania, Italy, where no folic acid fortification has been introduced but only supplementation in the periconceptional period is recommended. The main focus of our survey was to investigate the distribution of the MTHFR C677T polymorphism in relation to women's year of birth and to assess their folate intake and folic acid supplementation by the use of a food frequency questionnaire (FFQ).
Materials and methods

Study population
During a 6-months period, 307 healthy women of childbearing age, referred to the Laboratory of the S Bambino Hospital, Catania, Italy, an obstetric center for preconceptional, prenatal and/or postpartum care, were enrolled in the study. All women gave their informed consent to participate in the study. The study protocol was approved by the involved institutions. Fasting venous blood samples were collected, from each women, in EDTA-containing tubes and aliquots were stored at À80 1C until analysis.
Data were collected by trained interviewers using a structured questionnaire to obtain information on demographic and lifestyle data, including smoking habits and obstetrical history. The use of multimineral/multivitamin from supplements, including folic acid supplements, were derived from questions addressing the consumption of dietary supplements during the periconceptional period and pregnancy. Women were asked whether they used vitamin and mineral supplements and which supplement (type or brand) they used, and thus classified as taking or not taking supplements.
Body mass index was calculated as weight (kg) divided by height (m 2 ), based on criteria from the World Health Organization (1995). Pre-pregnancy body mass index was based on self-reported pre-pregnancy weight. Furthermore, estimated folate intakes were ranked by tertiles using the dietary assessment approach and the rankings were compared across baseline characteristics of enrolled women.
The validity of folate intake estimates from the FFQ was assessed. In brief, a random sub-sample of 30 women from the study population (validation study subgroup) was asked to complete both the FFQ and, afterwards, a 4-days weighted dietary record (WDR) that covers 3 weekdays and 1 weekend day. A booklet with pictures of common food items and mixed dishes were used to facilitate the estimation of portion sizes. Folate intake from WDR was calculated using the methods describe for FFQ analysis. Associations between individual folate intake estimated from the FFQ and the WDR were assessed by Spearman's correlation coefficient and by ratios between intakes based on the test and reference method.
MTHFR C677T and A1298C genotyping Genomic DNAs were extracted from whole blood using the Illustra blood genomicPrep Mini Spin Kit (GE Healthcare, Niskayuna, NY, USA) according to the manufacturer's protocol and stored at À20 1C.
Determination of MTHFR C677T and A1298C polymorphisms was performed using the TaqMan allelic discrimination Assay, using the Applied Biosystems 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Allelic discrimination was carried out by measuring fluorescence intensity at the endpoint. The results of the measurement and subsequent genotype were evaluated with SDS software version 2.3 (Applied Biosystems).
Statistical analyses
Statistical analyses were performed using the software SPSS, version 14.0 (SPSS). The w 2 -test was used for the statistical comparison of proportions. Continuous variables were tested using Student's t-test. The basic significance level was fixed at Po0.05.
To ascertain if population sample was in Hardy-Weinberg equilibrium for the MTHFR polymorphisms, a w 2 -test was performed.
Results
Population characteristics
During the study period, between July and October 2008, all women of childbearing age attending the laboratory to have a blood test were invited to participate in the study. A total of 307 women were enrolled. The main characteristics of the women enrolled in the study are shown in Table 1 . The mean age was 28.9 years (median 28 years; range: 14-49 years). The majority (94%) of women were born in Italy and 45% were pregnant. Particularly, 43.8% of pregnant women were in the third trimester of pregnancy.
Folate intake A total of 43.3% of enrolled women reported the use of folic acid supplements or of multimineral/multivitamin supplements containing folic acid. Particularly, 87.0% of pregnant women and 7.7% of non-pregnant women taking folic acid supplements (P ¼ 0.000). Reported use of folic acid supplements increased significantly from 71.4% of women in the first trimester of pregnancy to 88.1% in the second trimester and up to 95.0% in the third trimester (Table 2 ; P ¼ 0.001).
In the validation study subgroup, the mean folate intake, estimated by the FFQ, was 215.5 mg per day, and of 164.2 mg per day estimated by the WDR. Median intake estimated by the FFQ was 222.0 mg per day, and of 161.0 mg per day estimated by the WDR. Intake median ratio was of 1.38 (FFQ/ WDR), thus, intake of folate was 38% higher, as estimated by FFQ versus WDR. Spearman's correlation coefficient was 0.59 (P ¼ 0.002).
For the overall population, the mean folate intake, assessed by the FFQ, was 208.5 mg per day (median 196.0 mg per day; range: 47.4-939.7 mg per day), 222.8mg per day (median 204.4 mg per day; range: 67.2-939.7 mg per day) for pregnant women and of 196.9 mg per day (median 186.7 mg per day; range: 47.4-579.3 mg per day) for non-pregnant women (P ¼ 0.026). Mean folate intake increased, but not significantly, during the three trimester of pregnancy (Table 2) .
Considering only diet and comparing the folate intake with estimated average requirement, the prevalence of inadequate folate intake was 90.2%, 89.9% and 90.5%, respectively, for the overall sample, for pregnant women and for non-pregnant women. The prevalence of inadequate folate intake was 94.3%, 88.1% and 88.3%, respectively, in the first, in the second and in the third trimester of pregnancy.
Taking into account the use of supplements, and thus classifying each woman as taking or not taking supplements, the prevalence of inadequate folate intake decreased to 51.5% overall and during the three trimesters of pregnancy (P ¼ 0.013).
Following the percentile distribution, the population was divided into four groups according to birth date and prevalence of inadequate folate intake-considering only diet, without taking into account intake from supplementswas compared between groups. An increase of the prevalence of inadequate folate intake (from 88.3 to 91.7%) was observed in the group of women born in 1985-1994 when compared with the older group born in 1959-1973. Inadequate folate intake was significantly larger among working women (61.7%) than housewives (43.7%; P ¼ 0.002) who tended to take folic acid supplements (51.1%) more than women working outside (33.1%; P ¼ 0.002), also after controlling for educational level. Inadequacy was significantly larger among overweight or obese women (58.5%) than among women with normal weight (45.0%; P ¼ 0.022). Furthermore, estimated folate intakes were ranked by tertiles and resulting rankings were compared across baseline characteristics of enrolled women. No statistically significant association was observed ( Table 2) .
Distribution of MTHFR C677T and A1298C polymorphisms
The distribution of MTHFR genotypes for the C677T and A1298C polymorphisms is shown in Table 3 . The allelic distribution of both MTHFR polymorphisms follows the Hardy-Weinberg equilibrium expectations (P ¼ 0.26). The relative frequencies of the 677T-and 1298C-mutated alleles were 43.8% and 30.5%, respectively. Overall, 20.5% of the subjects were homozygous for the 677TT-mutated genotype and 7.8% for the 1298CC-mutated genotype. The heterozygous status for both mutations was similar, 46.6% for the C677T mutation and 45.3% for the A1298C mutation.
Six of the nine possible genotype combinations were found for the two MTHFR polymorphisms, whereas no subjects had the MTHFR 677CT/1298CC, 677TT/1298CC or 677TT/1298AC genotype combination.
Genotype frequencies and age
Following the age percentile distribution, genotype frequencies of MTHFR polymorphisms were compared between groups. For the C677T polymorphism an increase of the TT genotype (from 14.3 to 28.2%; P ¼ 0.03) was observed in the group of women born in 1980-1984 when compared with the group of women born in [1959] [1960] [1961] [1962] [1963] [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] (Table 3) . Furthermore, an increase of the T-allelic frequency was shown from For the A1298C polymorphism no significant differences were observed in allelic or genotypic frequencies between the different groups (Table 4) .
Discussion
The MTHFR C677T has been a focus of increasing interest worldwide since its genetic identification in 1995, and accurate information on its distribution can contribute to studies of gene-disease associations. Our study, conducted in a sample of the women population in Sicily (southern Italy), reports a TT genotype frequency of 20.5%, consistently with previously published works. Notably, an increase in the prevalence of the TT genotype in the cohort of women born since 1959 was shown, although this finding should be interpreted with caution given the sample size.
A variation in the prevalence of the TT homozygous genotype was previously reported, with the presence of a north to south gradient. Particularly in Europe, this prevalence has been shown to increase from the lowest values in the north (4-7%), to the highest frequencies in southern Italy (20.1 and 19.9% in Sicily; Wilcken et al., 2003; Guéant-Rodriguez et al., 2006) . The mechanisms generating this gradient are not clearly known, although it has been hypothesized that they could involve, at least in part, genenutrient interactions and that in Europe dietary folate may have influenced the prevalence of the T allele (Guéant-Rodriguez et al., 2006) . In fact, some results obtained in subgroups of the European populations confirmed a south to north decreasing gradient of dietary folate intake and of the T-allele frequency: a high frequency of the TT genotype in the presence of a high concentration of folate in plasma and a low frequency in the presence of low folate concentrations have been reported (Guéant-Rodriguez et al., 2006) .
Our cross-sectional study was conducted on women of childbearing age in Catania, Italy, in which no folic acid fortification has been introduced but only supplementation in the periconceptional period is routinely recommended since the 1980s. The observed increase of the T-allelic frequency in the group of women in study, born in the last quarter of the last century, has been already associated with some selective advantage in a previous research conducted on a Spanish population (Mayor-Olea et al., 2008) . Particularly, it has been reported that selection in favor of the T allele could be due to the increased fetal viability in early stages of embryonic development due to an increase in folic acid and vitamin supplements intake by women in the periconceptional period that began to be established in Spain in the last quarter of the 20th century as well as it started in other European countries including Italy (MayorOlea et al., 2008) .
Previous studies have suggested that the MTHFR TT homozygosity may confer a survival advantage in populations with adequate dietary folate consumption (MunozMoran et al., 1998; Rosenberg et al., 2002; Guéant-Rodriguez et al., 2006) . The T allele is associated with a greater risk of neural tube defects in those geographical areas or ethnic groups with a high frequency of this genotype, but that risk seems to be neutralized by a diet rich in folate, such as the Mediterranean diet (Zetterberg, 2004) . In fact, in southern Italy, the TT genotype is common, but the rate of neural tube defects is not particularly high (International Clearinghouse for Birth Defects Monitoring Systems, 2001), probably because environmental and nutritional factors are likely to modulate the risk (Wilcken et al., 2003) .
In the present study, using the validated FFQ, taking into account the folic acid supplements and comparing the 1959-1973 1974-1979 1980-1984 1985-1994 overall intake with estimated average requirement, the prevalence of inadequate folate intake was 51.5%, significantly higher in non-pregnant women (83.4%) than in pregnant ones (12.3%). Furthermore, the prevalence of inadequate folate intake significantly decreased during the three trimesters of pregnancy (from 25.7 to 5.0%; P ¼ 0.013). These findings may be the result of the higher use of folic acid supplements in pregnancy (87.0%) compared with the lower use in non-pregnant women (7.7%). Our results show that the use of folic acid supplements increased significantly during the three trimester of pregnancy (from 71.4 to 95.0%; P ¼ 0.001). Intake of multimineral/multivitamin from supplements during pregnancy is an attractive option to improve the nutritional status of pregnant women. However, although it has been recently reported that the daily use of multivitamin and mineral supplements (mainly folic acid) during any stage in pregnancy is not associated with lower birthweight and taking supplements in the third trimester has been associated with a threefold increased risk of preterm delivery (Alwan et al., 2010) . Even if those findings need to be confirmed by other cohorts and/or trials, they suggest that clinicians should be cautious when recommending multivitamin-mineral supplements to women in late pregnancy due to the possible implications in the pregnancy outcome.
Nutritional status and food consumption may be important HPV cofactors that increase risk of persistence and progression to CIN. Using the validated FFQ, a high prevalence of folate intake inadequacy has been shown along with an increase in mutated MTHFR C677T polymorphism that may modulate the risk of cancer according to folate status (Henao et al., 2005; Piyathilake et al., 2007; Flatley et al., 2009 ). According to our study, healthy young women may have higher folate needs due to the increased prevalence of the T allele and reduced folate intake compared with older groups.
In interpreting the findings of this study, its limitations should be considered. First, we have not analyzed biomarkers of folate status, as our aim was to measure habitual folate intake over an extended period of time, although biomarkers of folate status could have helped us to better define folate inadequacy and to validate our FFQ. All dietary assessment instruments are associated with different, and sometimes considerable, random and systematic measurement errors (Kristal and Potter, 2006; Willett and Hu, 2007; OrtizAndrellucchi et al., 2009) and thus, when possible, biomarkers have to be incorporated into the validation of dietary assessment methods (Jenab et al., 2009) , because folate biomarkers are very robust and sensitive markers of folate status. However, it has been reported that biomarkers are affected by different sources of error than FFQs, such as variation over time probably reflecting changes in intake, and, on the contrary, the advantages of using FFQs include measuring usual food intake over an extended period, allowing for large study samples (Johansson et al., 2010) . Besides, this study was not designed to measure other important protective micronutrients, such as other B-vitamins for example, riboflavin) or antioxidants (for example, vitamins C, A, E and carotenes), and this could be an important limitation of the study, nevertheless the FFQ used in our study was designed and validated using WDR, in order to estimate only folate intake, with a correlation coefficient of 0.59, in accordance with other FFQ validation studies (Erkkola et al., 2001; French et al., 2001; Flood et al., 2004; Johansson et al., 2010) .
Therefore, future studies, carefully designed to address the above limitations, are needed to further our knowledge about the critical role of maternal nutrition and, in particular, of micronutrients to reproductive health. Furthermore, potential implications for folate requirements are highlighted by our results. Healthy young women may have higher folate needs due to reduced folate intake compared with older groups and moreover they show an increasing prevalence of the T allele, which in turn may require supplement recommendation. Besides, appropriate timing of supplement use should be advised in order to prevent a poor pregnancy outcome, as it has been previously suggested to occur in the late pregnancy (Alwan et al., 2010) . Welldesigned-randomized controlled trials are needed to investigate the role of multivitamin supplement use in late pregnancy.
Conflict of interest
The authors declare no conflict of interest.
